The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index.
Prediction of Mortality in Patients with Cystic Fibrosis
Abstract
BACKGROUND: The majority of patients with cystic fibrosis die in early adulthood of lung disease. Lung transplantation is a treatment option for patients with advanced pulmonary disease, although the waiting period for organs may be as long as two years. Our purpose was to determine whether the risk of death due to respiratory failure could be predicted one or two years in advance on the basis of pulmonary function, blood gas levels, and nutritional status. METHODS: The study cohort consisted of 673 patients followed between 1977 and 1989. In each patient, pulmonary function, blood gas levels, nutritional status, and vital status were assessed between 1977 and 1987. Cox proportional-hazards regression analysis was used to compute the relative risk of death within one or two years after particular measurements. The effects of age and sex on mortality were also included in the analysis. RESULTS: One hundred ninety patients (28 percent) died during the study period. Overall, patients with a forced expiratory volume in one second (FEV1) less than 30 percent of the predicted value, a partial pressure of arterial oxygen below 55 mm Hg, or a partial pressure of arterial carbon dioxide above 50 mm Hg had two-year mortality rates above 50 percent. Among the laboratory measurements, the FEV1 was the most significant predictor of mortality, but age and sex were also significant in predicting risk. After adjustment for age and sex, the relative risk of death within two years was 2.0 (95 percent confidence interval, 1.9 to 2.2) for each decrement in the FEV1 of 10 percent below the predicted value. Among patients with the same FEV1, the relative risk of death was 2.0 (95 percent confidence interval, 1.5 to 2.6) in patients 10 years younger than other patients, and 2.2 (1.6 to 3.1) in female patients as compared with male patients. CONCLUSIONS: Patients with cystic fibrosis should be considered candidates for lung transplantation when the FEV1 falls below 30 percent of the predicted value. Female patients and younger patients may need to be considered for transplantation at an earlier stage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FEV1 has been the best individual predictor of mortality in CF, with studies from the 1990s demonstrating a median survival of 2–4 years after reaching an FEV1 < 30% predicted.(242–244)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [243]
In the citing paper
“FEV1 has been the best individual predictor of mortality in CF, with studies from the 1990s demonstrating a median survival of 2–4 years after reaching an FEV1 < 30% predicted.(242–244)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [243]
In the citing paper
“FEV1 is a strong predictor of clinical status in cystic fibrosis,20 and elexacaftor–tezacaftor–ivacaftor resulted in sustained improvements in this end point.”
From Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele (2019) · cites this paper as [20]
Citations
Cites
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Tanner, J. M., Whitehouse, R. H., & Takaishi, M. (1966) · Archives of Disease in Childhood · doi:10.1136/adc.41.220.613 · Cited by 2,553
Corey, M., McLaughlin, F. J., Williams, M., & Levison, H. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90063-7 · Cited by 815
Self-citationCystic fibrosis: current survival and population estimates to the year 2000.
Elborn, J. S., Shale, D. J., & Britton, J. R. (1991) · Thorax · doi:10.1136/thx.46.12.881 · Cited by 351
Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis
Huang, N. Ν., Schidlow, D. V., Szatrowski, T. H., Palmer, J., Laraya-Cuasay, L. R., Yeung, W. H., Hardy, K. A., Quitell, L., & Fiel, S. B. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90147-1 · Cited by 112
The Shortage of Organs for Transplantation: Where Do We Go from Here?
Spital, A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251710 · Cited by 107
Effects of social class, sex, and region of residence on age at death from cystic fibrosis.
Britton, J. R. (1989) · BMJ · doi:10.1136/bmj.298.6672.483 · Cited by 105
HEART-LUNG TRANSPLANTATION FOR CYSTIC FIBROSIS
SCOTT, J., Higenbottam, T., Hutter, J., Hodson, M. E., Stewart, S., Penketh, A., & Wallwork, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92290-8 · Cited by 98
Heart-lung transplantation: Better use of resources
Hutter, J. A., Despins, P., Higenbottam, T., Stewart, S., & Wallwork, J. L. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90496-2 · Cited by 82
British Medical Journal Publishing Group (1988) · BMJ · doi:10.1136/bmj.297.6663.1599 · Cited by 75
Research works printed but not linked: 5
- MacLusky I, Levison H. Cystic fibrosis. In: Chernick V, ed. Disorders of the respiratory tract in children. 5th ed. Philadelphia: W.B. Saunders, 1990: 692–729.
- Wood RE. Prognosis. In: Taussig LM, ed. Cystic fibrosis. New York: Thieme-Stratton, 1984:434–60.
- Corey ML. Longitudinal studies in cystic fibrosis. In: Sturgess JM, ed. Perspectives in cystic fibrosis: Proceedings of the Eighth International Congress on Cystic Fibrosis. Mississauga, Ont.: Imperial Press, 1980:24655.
- Canny, 1986, Pediatr Pulmonol, 2, 313
- Wagener JS, Taussig LM, Burrows B, Hernried L, Boat T. Comparison of lung function and survival patterns between cystic fibrosis and emphysema or chronic bronchitis patients. In: Sturgess JM, ed. Perspectives in cystic fibrosis: Proceedings of the Eighth International Congress on Cystic Fibrosis. Mississauga, Ont.: Imperial Press, 1980:236–45.
Cited by
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
Middleton, P. G., Mall, M. A., Dřevínek, P., Lands, L. C., McKone, E. F., Polineni, D., Ramsey, B. W., Taylor-Cousar, J. L., Tullis, E., Vermeulen, F., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908639 · Cited by 2,198
Carnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
“In 1992, Kerem et al 36 reported that FEV 1 o 30% of predicted was associated with a 2-year mortality rate of approximately 40% in men and 55% in women.”
Metadata
- Authors
- Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H.
- Affiliations
- Hospital for Sick Children (CA)
- ORCID
- Kerem, Eitan
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-04-30
- Volume
- 326
- Issue
- 18
- Pages
- 1187-1191
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2313949504
- Semantic Scholar
- c41c585ed77d31fbb851aa8e4c71b200df1c4ae3
- Cited by
- 993
- References
- 19
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 12 · 2023: 18 · 2022: 19 · 2021: 43 · 2020: 44 · 2019: 27 · 2018: 39 · 2017: 44 · 2016: 29 · 2015: 33 · 2014: 44 · 2013: 36 · 2012: 46
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- cystic fibrosis, mortality prediction, lung transplantation, respiratory failure, lung function, FEV1, hypoxemia, hypercapnia, nutritional status, age and sex risk factors, transplant eligibility
- MeSH terms
- Adolescent, Adult, Body Weight, Carbon Dioxide, Child, Child, Preschool, Cystic Fibrosis, Female, Forced Expiratory Volume, Humans, Infant, Male, Oxygen, Partial Pressure, Prognosis, Regression Analysis, Respiratory Insufficiency, Risk, Sex Factors, Vital Capacity, Lung Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of Mortality in Patients with Cystic Fibrosis. https://app.cochat.ai/papers/10.1056/nejm199204303261804
- The paper
- Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992). Prediction of Mortality in Patients with Cystic Fibrosis. New England Journal of Medicine. https://doi.org/10.1056/nejm199204303261804
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.